- CH₣2.32bn
- CH₣2.49bn
- €510.78m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 31.63 | ||
| PEG Ratio (f) | 1.19 | ||
| EPS Growth (f) | 36.06% | ||
| Dividend Yield (f) | 0.69% | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 7.23 | ||
| Price to Tang. Book | 8.56 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 4.67 | ||
| EV to EBITDA | 19.37 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 13.62% | ||
| Return on Equity | 15.66% | ||
| Operating Margin | 14.57% | ||
Financial Summary
| Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | €m | 310.62 | 302.49 | 363.13 | 437.12 | 510.78 | 591.06 | 669.68 | 13.38% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | -0.63 | -20.02 | +61.88 | -10.36 | -7.46 | +46.96 | +17.45 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Medacta International SA is a Swiss-based company specialized in medical devices. The Company develops, manufactures and distributes orthopaedic and neurosurgical medical devices. The Company designs a number of products, such as hip products, including hip replacement, hip anatomy, hip diseases, and other products for the preparation of hip surgery; knee product, which encompasses knee anatomy, knee diseases, knee replacement, the stability of the knee and for the preparation of knee surgery; shoulder product, which includes shoulder anatomy, shoulder disease, shoulder replacement, and for the preparation of shoulder operation, and spine product, which includes products for spinal treatments, spinal anatomy and for surgery, among others. Additionally, the Company also offers training and support to healthcare professionals.
Directors
- Alberto Siccardi NEC (77)
- Francesco Siccardi CEO (44)
- Corrado Farsetta CFO (53)
- Alessandro Siccardi OTH (35)
- Victor Balli LED (64)
- Maria Siccardi Tonolli NED (46)
- Riccardo Braglia NID (61)
- Philippe Weber NID (56)
- Last Annual
- December 31st, 2023
- Last Interim
- December 31st, 2023
- Incorporated
- November 30th, 2018
- Public Since
- April 4th, 2019
- No. of Employees
- 1,730
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
SIX Swiss Exchange- Shares in Issue
- 19,927,500
- Address
- Strada Regina 34, CASTEL SAN PIETRO, 6874
- Web
- http://www.medacta.com/
- Phone
- Contact
- Strada Regina
- Auditors
- Deloitte SA
Upcoming Events for MOVE
Medacta Group SA Annual Shareholders Meeting
Dividend For MOVE.S - 0.2750 CHF
Dividend For MOVE.S - 0.2750 CHF
Mirabaud Swiss Equities Conference
Medacta Group SA at Mirabaud Investor Conference
Medacta Group SA at JP Morgan European Healthcare Conference
Half Year 2024 Medacta Group SA Unaudited Top Line Figures
Half Year 2024 Medacta Group SA Earnings Release
Similar to MOVE
Alcon AG
SIX Swiss Exchange
COLTENE Holding AG
SIX Swiss Exchange
IVF Hartmann Holding AG
SIX Swiss Exchange
Medartis Holding AG
SIX Swiss Exchange
medmix AG
SIX Swiss Exchange
FAQ
What is the Medacta SA share price?
As of Today at 19:13 UTC, shares in Medacta SA are trading at CH₣116.40. This share price information is delayed by 15 minutes.
How has the Medacta SA share price performed this year?
Shares in Medacta SA last closed at CH₣116.40 and the price had moved by +8.79% over the past 365 days. In terms of relative price strength the Medacta SA share price has outperformed the FTSE Global All Cap Index by +0.34% over the past year.
What are the analyst and broker recommendations for Medacta SA?
The overall consensus recommendation for Medacta SA is Buy. You can view the full broker recommendation list by unlocking its StockReport.
What is the Medacta SA dividend yield?
The Medacta SA dividend yield is 0.49% based on the trailing twelve month period.
Does Medacta SA pay a dividend?
Last year, Medacta SA paid a total dividend of €0.59, and it currently has a trailing dividend yield of 0.49%.Looking ahead, shares in Medacta SA are due to go ex-dividend on 2024-05-10 and the next dividend pay date is 2024-05-14.
When does Medacta SA next pay dividends?
Medacta SA are due to go ex-dividend on 2024-05-10 and the next dividend pay date is 2024-05-14. The historic dividend yield on Medacta SA shares is currently 0.49%.
How do I buy Medacta SA shares?
To buy shares in Medacta SA you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Medacta SA?
As of the previous close price of CH₣116.40, shares in Medacta SA had a market capitalisation of CH₣2.32bn.
Where are Medacta SA shares listed?
Here are the trading details for Medacta SA:
- Country of listing: Switzerland
- Exchange: SWX
- Ticker Symbol: MOVE
What kind of share is Medacta SA?
Based on an overall assessment of its quality, value and momentum Medacta SA is currently classified as a High Flyer. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Medacta SA share price forecast for 2024?
The analyst consensus target price for shares in Medacta SA is CH₣142.84. That is 22.72% above the last closing price of CH₣116.40.
Analysts covering Medacta SA currently have a consensus Earnings Per Share (EPS) forecast of €3.60 for the next financial year.
What is the trend in the Medacta SA share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Medacta SA. Over the past six months, its share price has underperformed the FTSE Global All Cap Index by -7.82%.
As of the last closing price of CH₣116.40, shares in Medacta SA were trading -3.96% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Medacta SA PE Ratio?
The Medacta SA PE ratio based on its reported earnings over the past 12 months is 31.63. The shares last closed at CH₣116.40.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Medacta SA?
Medacta SA's management team is headed by:
- Alberto Siccardi - NEC
- Francesco Siccardi - CEO
- Corrado Farsetta - CFO
- Alessandro Siccardi - OTH
- Victor Balli - LED
- Maria Siccardi Tonolli - NED
- Riccardo Braglia - NID
- Philippe Weber - NID